Clinical Science · Research · 2026

Oxygen Nanobubble Delivery to Human Skin

Oxygenation, Barrier Integrity, and Adaptive Defense Response

Evidence from HIF-1α, NQO1, and HO-1 Biomarker Analysis

Research led by Zvi Yaniv, PhD  ·  Vivian Bucay, MD  ·  Giuseppe Valacchi, PhD  —  NC State University

5Subjects
3Time Points
4Key Biomarkers
100%Barrier Intact
Study Presentation

Watch Dr. Valacchi Present the Findings

In collaboration with North Carolina State University, AO2 SKIN tested whether topical oxygen nanobubbles could measurably improve oxygen availability in human skin. Using HIF-1α, the skin’s natural oxygen-response marker, researchers found a significant reduction after application, indicating improved oxygen delivery into the epidermis and dermis.

In this video, Dr. Giuseppe Valacchi of NC State University walks through the study design, methodology, data, and conclusions in detail.

Dr. Giuseppe Valacchi, PhD, NC State University · AO2 SKIN Clinical Science Presentation, 2026

Research Team

Meet the Experts Behind the Study

This research was designed and conducted by three World-class doctors with deep expertise in dermatology, nanotechnology, and redox biology.

Dr. Zvi Yaniv, PhD

Dr. Zvi Yaniv, PhD

Chief Science Officer
AO2 SKIN
Nanotechnology pioneer with over 300 patents. The scientific architect behind AO2 SKIN’s oxygen nanobubble delivery technology.
Vivian Bucay, MD, FAAD

Vivian Bucay, MD, FAAD

Chief Medical Officer
AO2 SKIN
Johns Hopkins and Baylor College of Medicine graduate. Considered one of the pre-eminent dermatologists in the United States. Oversaw all skin biopsies in this study.
Giuseppe Valacchi, PhD

Giuseppe Valacchi, PhD

Distinguished Professor
NC State University — Regenerative Medicine
World-leading expert in redox biology and skin science. Coined the term “OxInflammation” and holds NC State’s highest faculty distinction.
AO2 SKIN TECHNOLOGY CHALLENGE

Increase Skin Oxygenation, Proving it Biochemically

What we say it does. What the research shows.

Oxygen

A powerful antibacterial that is pure, natural, and the ideal opponent for anaerobic bacteria, the root cause of acne.

Nanobubbles

Measured at one-billionth of a meter, they are 1,000× smaller than your skin pores, making them the ideal delivery vehicle.

Concentration Gradient

High oxygen concentration in AO2 creates a dramatic gradient, allowing oxygenated nanobubbles to flood pores and clear anaerobic bacteria.
AO2 SKIN oxygen nanobubble delivery technology visualization
Scientific Context

The Complex Structure of Skin and Its Oxygen Gradients

Human skin is not a uniform tissue, it maintains distinct oxygen tensions across the epidermis and dermis due to its layered anatomical structure. These gradients are measurable and, critically, measurably responsive to topical intervention. To validate that AO2 SKIN truly delivers oxygen into the tissue, not just onto the surface, the research team selected HIF-1α (Hypoxia-Inducible Factor 1-alpha) as the primary biomarker. This is the gold standard for measuring tissue oxygenation at the cellular level.
Skin oxygen gradient cross-section diagram

Oxygen tension gradients across skin layers (epidermis to dermis)

HIF-1α mechanism diagram

HIF-1α degradation pathway under normal vs. low oxygen conditions

Biomarker Science

HIF-1α: The Body’s Oxygen Alarm Signal

HIF-1α (Hypoxia-Inducible Factor 1-alpha) is the master transcription factor that regulates how cells respond to low oxygen levels. It is the most validated, widely-used indicator of tissue hypoxia in clinical research.

Under Normal Oxygen

HIF-1α is continuously degraded by the cell. No alarm signal is needed — the tissue is well-oxygenated.

Under Low Oxygen (Hypoxia)

HIF-1α accumulates, translocates to the nucleus, binds to DNA, and activates stress-response genes.
Clinical Conclusion: If HIF-1α decreases after treatment, that is direct biochemical proof of improved tissue oxygenation.
Biomarker Science

HIF-1α: The Body’s Oxygen Alarm Signal

HIF-1α (Hypoxia-Inducible Factor 1-alpha) is the master transcription factor that regulates how cells respond to low oxygen levels. It is the most validated, widely-used indicator of tissue hypoxia in clinical research.

Under Normal Oxygen

HIF-1α is continuously degraded by the cell. No alarm signal is needed, the tissue is well-oxygenated.

Under Low Oxygen (Hypoxia)

HIF-1α accumulates, translocates to the nucleus, binds to DNA, and activates stress-response genes.
Clinical Conclusion: If HIF-1α decreases after treatment, that is direct biochemical proof of improved tissue oxygenation.
HIF-1α mechanism diagram

HIF-1α degradation pathway under normal vs. low oxygen conditions

Study Design

Clinical Experimental Conditions

Study design and biopsy site diagram

Biopsy collection protocol and anatomical site selection

  • Volunters: 5
  • Time points: T0 (basal), T1 (30 min) and T2 (60 min)
  • Treatment: Topically applied Oxygen Nanobubbles
  • Skin samples: 3 biopsies (3mm) from the postauricular area

Study design:

Skin biopsies were collected from the postauricular area of five Volunteers, before and after treatment with topically applied Oxygen Nanobubbles for two points, i.e., 30 and 60 minutes after application. Skin biopsies will be processed for immunohistochemical analysis to evaluate the expression of HIF 1 alpha.

Study Results Overview

01Tissue Oxygenation.
Confirmed
02No Harmful Oxidative Stress.
Confirmed
03Cellular Defense Activated.
Confirmed
04Skin Barrier Fully Intact.
Confirmed
01 Tissue Oxygenation

HIF-1α Decreases Significantly After Treatment

In untreated skin, HIF-1α (shown as red staining) was present at elevated levels, indicating the tissue was operating under relative hypoxia. After AO2 SKIN application, HIF-1α decreased significantly at both 30 and 60 minutes. The blue staining in the imagery serves only as a nuclear marker, confirming healthy, non-apoptotic cells are present throughout all time points.
HIF-1α decreased significantly at T30 and T60 → direct biochemical evidence of improved tissue oxygenation.

This is not a surface effect. The reduction in HIF-1α is a cellular response occurring inside the tissue, confirming that oxygen has been delivered across the skin barrier and into the dermal layers.

HIF-1α immunofluorescence results at T0, T30, T60

HIF-1α expression (red staining) at T0 (baseline), T30, and T60 minutes post-application. Significant reduction confirms oxygenation.

Confirmed

The Decrease in HIF-1α Confirms Effective Tissue Oxygenation

HIF-1α is a validated biomarker of tissue hypoxia. Its reduction after topical application is the gold standard confirmation that oxygen has been successfully delivered to the tissue using AO2 SKIN.

02 Oxidative Stress Marker

4-HNE: No Harmful Oxidative Stress Induced

Delivering additional oxygen into tissue raises an important clinical question: Does it create damaging oxidative stress? The data clearly answers no.

4-HNE protein adduct results at T0, T30, T60

4-HNE (green staining) levels across treatment time points. No damaging increase detected.

About 4-HNE

4-HNE (4-Hydroxynonenal) is a stable marker of lipid peroxidation. At high concentrations, it forms protein adducts that cause cellular damage. At low levels, however, it functions as a beneficial signaling molecule that can activate the cell’s own defense pathways.
4-HNE showed no damaging elevation → confirming AO2 SKIN does not induce oxidative distress.
Hormetic eustress vs distress mechanism diagram

The hormetic dose-response: AO2 SKIN operates exclusively in the beneficial eustress range

Eustress vs. Distress: The Hormetic Principle

Not all oxidative signals are harmful. The dose makes the critical difference:

✓ Oxidative Eustress

Low-level, targeted signaling. Activates cellular defense pathways. Protective and physiological. This is where AO2 SKIN operates.

✕ Oxidative Distress

High-level, untargeted damage. Disrupts redox signaling. Harmful to cells and tissue structure.
03 Antioxidant Defense System

AO2 SKIN Activates the Skin's Own Cellular Defense

The NRF2 pathway is the master switch for the skin's antioxidant defense system. When activated, it triggers downstream protective enzymes. The study measured all three components of this pathway.

NRF2 cellular defense pathway diagram

NRF2 → The Master Defense Transcription Factor

NRF2 is the sensor that detects oxidant signals and initiates the antioxidant cellular defense response. When activated, it migrates to the nucleus, binds to DNA, and transcribes key protective enzymes. An upward trend in NRF2 was observed, driving significant increases in its downstream targets.

NQO1

Significantly Increased at T30

✓ Statistically Significant
NQO1 immunofluorescence results NQO1 is a protective enzyme regulated by NRF2. Its significant increase at 30 minutes confirms that AO2 SKIN activates the skin's own antioxidant defense system. Your skin becomes measurably stronger within 30 minutes of application.
HO-1

Continues Rising Through T60, Sustained

✓ Sustained & Growing
HO-1 immunofluorescence results Unlike NQO1, HO-1 keeps increasing through the full 60-minute observation window. This suggests a sustained activation of cellular defense, protecting the skin from environmental stressors long after application.

Defense Pathway Summary

Marker Role T30 Result T60 Result
NRF2 Master transcription factor Upward trend Continued trend
NQO1 Defensive antioxidant enzyme ✓ Significant increase Transient decrease
HO-1 Sustained protective enzyme ✓ Significant increase ✓ Continued rising
NRF2
Role: Master transcription factor
T30: Upward trend
T60: Continued trend
NQO1
Role: Defensive antioxidant enzyme
T30: ✓ Significant increase
T60: Transient decrease
HO-1
Role: Sustained protective enzyme
T30: ✓ Significant increase
T60: ✓ Continued rising
04 Skin Barrier Integrity

Filaggrin Remains Completely Undisturbed

Filaggrin is the structural protein essential for skin barrier function and hydration regulation. It is incorporated into the lipid envelope of the stratum corneum and is a critical marker for epidermal homeostasis. To confirm the safety and hormetic (beneficial) nature of AO2 SKIN’s effects, the skin barrier structure must remain perfectly intact throughout treatment. Any disruption to filaggrin would indicate damage rather than benefit.
Filaggrin levels remained unchanged across T0, T30, and T60 → confirming zero disruption to the skin barrier.

This is clinically significant for skincare professionals: AO2 SKIN activates robust cellular defense responses while leaving the skin’s structural integrity completely undisturbed. The treatment is both effective and safe.

Barrier Status
100% Intact Across All Time Points
Filaggrin immunofluorescence results at T0, T30, T60

Filaggrin expression (red staining) remains stable across all time points. No disruption to skin barrier structure detected.

Study Conclusions

What the Science Confirms

01

Oxygen Delivery Confirmed

HIF-1α decreased significantly at both T30 and T60 providing direct biochemical evidence of improved tissue oxygenation. This is not anecdotal; it is measurable at the cellular level.

02

No Oxidative Distress, Only Eustress

4-HNE results confirm a transient, beneficial oxidative signal, not damaging stress. AO2 SKIN operates exclusively in the hormetic eustress range, where signals are protective, not harmful.

03

Cellular Defense System Activated

NQO1 was significantly elevated at T30. HO-1 continued rising through T60. The skin’s own antioxidant defense enzymes are measurably strengthened, and the effect is sustained.

04

Skin Barrier Fully Intact

Filaggrin levels remained completely unchanged across all time points. The treatment activates powerful cellular defense responses without any disruption to skin barrier structure or integrity.

“AO2 SKIN is able to deliver oxygen to the skin as measured by HIF-1α. The increase of oxygen does not induce oxidative distress, but most likely an oxidative eustress, the good one. The skin is much more able to defend itself from other stressors that could come after the application of this compound.”
Giuseppe Valacchi, PhD  ·  David H. Murdock Distinguished Professor of Regenerative Medicine, NC State University